Table 3. Cytokine Concentrations at baseline.
| Control mean ±SD | BMMNC mean ±SD | P-value | |
|---|---|---|---|
| IL-1b † | 0.5 ±0.2 | 0.5 ±0.4 | 0.60 |
| IL-1ra † | 35.3 ±47.3 | 21.7 ±24.2 | 0.38 |
| IL-2 † | 4.9 ±6.6 | 2.7 ±2.2 | 0.27 |
| IL-4 † | 4.5 ±2.7 | 4. ±1.9 | 0.09 |
| IL-5 † | 1.9 ±1.2 | 1.7 ±0.9 | 0.56 |
| IL-6 † | 4.9 ±3.2 | 5.7 ±4.7 | 0.58 |
| IL-7 † | 2.4 ±2.1 | 1.9 ±0.9 | 0.42 |
| IL-8 † | 6.0 ±5.0 | 4.9 ±3.6 | 0.53 |
| IL-9 † | 2.7 ±2.1 | 2.5 ±1.9 | 0.83 |
| IL-10 † | 11.9 ±22.7 | 2.6 ±8.4 | 0.13 |
| IL-12 † | 25.3 ±32.3 | 11.0 ±5.3 | 0.11 |
| IL-13 † | 6.6 ±7.2 | 3.9 ±1.2 | 0.18 |
| IL-15 † | 6.1 ±0.9 | 6.9 ±3.1 | 0.37 |
| IL-17 † | 2.4 ±2.1 | 1.9 ±0.9 | 0.29 |
| Eotaxin | 15.6 ±10.6 | 16.7 ±9.6 | 0.77 |
| Fibroblast growth factor (FGF)basic † | 8.4 ±14.3 | 4.5 ±5.8 | 0.35 |
| Granulocyte growth stimulating factor (G-CSF) † | 14.5 ±13.3 | 12.2 ±8.4 | 0.59 |
| Granulocyte-macrophage colony stimulating factor (Gm-CSF) † | 11.8 ±1.2 | 11.8 ±1.2 | 1.00 |
| Interferon-γ (IFNγ) † | 17.3 ±25.5 | 13.3 ±19.4 | 0.65 |
| IP-10 | 140.9 ±37.7 | 151.1 ±59.1 | 0.61 |
| MCP-1/MCAF † | 9.6 ±8.7 | 12.0 ±14.7 | 0.62 |
| MIP-1a † | 1.7 ±1.7 | 1.5 ±1.0 | 0.69 |
| MIP-1β | 18.1 ±10.6 | 15.8 ±5.7 | 0.47 |
| RANTES* | 21081.0 ±9016.9 | 22284.6 ±6016.4 | 0.68 |
| Tumor necrose factor-α (TNF-α) † | 5.7 ±4.1 | 5.7 ±5.0 | 0.99 |
| Vascular endothelial growth factor (VEGF) † | 48.0 ±102.1 | 23.3 ±15.8 | 0.38 |
† = concentrations under the threshold of the standard line were included
* = concentrations over the threshold of the standard line were included